A favorable follicular helper CD4 T cell programming characterizes neutralization activity in chronic HIV infection.

Saved in:
Bibliographic Details
Title: A favorable follicular helper CD4 T cell programming characterizes neutralization activity in chronic HIV infection.
Authors: Moysi E; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Sharma AA; Pathology Advanced Translational Research Unit, Department of Pathology, Emory University School of Medicine, Atlanta, United States of America., O'Dell S; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Georgakis S; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Del Rio Estrada PM; Pathology Advanced Translational Research Unit, Department of Pathology, Emory University School of Medicine, Atlanta, United States of America., Khader G; Pathology Advanced Translational Research Unit, Department of Pathology, Emory University School of Medicine, Atlanta, United States of America., Arana A; Pathology Advanced Translational Research Unit, Department of Pathology, Emory University School of Medicine, Atlanta, United States of America., Torres-Ruiz F; Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., González Navarro M; Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Luna Villalobos YA; Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Avila Rios S; Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosío Villegas', Mexico City, Mexico., Reyes-Teran G; Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Secretaría de Salud de México, Mexico City, Mexico., Beddall MH; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Ko SH; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Belinky F; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Orfanakis M; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., de Leval L; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Enriquez AB; Pathology Advanced Translational Research Unit, Department of Pathology, Emory University School of Medicine, Atlanta, United States of America., Buckner CM; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Lindsay H; Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Gottardo R; Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Doria-Rose N; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Boritz EA; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Mascola JR; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Sekaly RP; Pathology Advanced Translational Research Unit, Department of Pathology, Emory University School of Medicine, Atlanta, United States of America., Koup RA; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America., Petrovas C; Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States of America.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI192575